Opportunity Information: Apply for CDC RFA GH15 1556SUPP16
Apply for CDC RFA GH15 1556SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Meeting PEPFAR’s accelerated targets for HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 08, 2016 and posted on Jan 08, 2016.
- Applicants must submit their applications by Mar 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Meeting PEPFAR's accelerated targets for HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded supplemental cooperative agreement designed to speed up progress toward HIV epidemic control in Mozambique. It is issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), under Funding Opportunity Number CDC RFA GH15-1556SUPP16 and CFDA 93.067. The award mechanism is a cooperative agreement, which typically means CDC expects to stay closely involved in program direction, oversight, and technical collaboration rather than simply providing funds with minimal involvement.
This supplemental funding is restricted in eligibility to JHPIEGO in Mozambique, meaning it is not an open competition for new applicants. The purpose is to expand or intensify work already being carried out by the existing grantee rather than launching a brand-new program from scratch. The opportunity was posted on January 8, 2016, with an application closing date of March 8, 2016, and CDC anticipated making one award. The published "award ceiling" is listed as 0, which often indicates the exact funding level is either determined through internal budgeting, provided elsewhere in the announcement package, or negotiated based on the approved supplemental scope rather than set as a firm maximum in the public synopsis.
The public health rationale is grounded in Mozambique's generalized HIV epidemic, with an estimated adult prevalence of about 11.5% among people ages 15 to 49. The announcement also highlights a major structural barrier to scaling services: Mozambique faces one of the most severe health care worker shortages globally. In practical terms, that shortage can limit the pace at which HIV testing, treatment initiation, retention services, and prevention interventions can be expanded, even when medications and commodities are available.
Programmatically, the supplemental award supports PEPFAR's "accelerated plan" in Mozambique, which aligns U.S. Government priorities with the UNAIDS Fast-Track 90-90-90 targets. Those targets focus on ensuring that 90% of people living with HIV know their status, 90% of those diagnosed receive sustained antiretroviral therapy, and 90% of those on therapy achieve viral suppression. The announcement frames the accelerated plan as part of broader PEPFAR policy objectives, including the AIDS-Free Generation policy direction, emphasizing rapid scale-up of high-impact interventions to bend the curve of new infections and HIV-related deaths.
The key service delivery goal stated in the opportunity is to reach 80% coverage for HIV treatment in prioritized districts, alongside accelerated coverage for other core HIV services. Those include HIV testing and counseling to identify people living with HIV earlier, prevention of mother-to-child transmission (PMTCT) to reduce infant infections and improve maternal outcomes, and voluntary medical male circumcision (VMMC) as a proven prevention strategy in generalized epidemics. Rather than describing a brand-new set of activities, the announcement makes clear that the supplemental work is meant to build directly on the current grantee's existing platform and ongoing implementation, essentially increasing the speed and intensity of delivery to meet the accelerated targets.
Geographically, the supplemental activities are focused on several priority provinces and urban areas: Zambezia, Sofala, Gaza, Maputo Province, and Maputo City. By concentrating efforts in these locations, the award supports a targeted approach typical of PEPFAR acceleration strategies, where resources are directed to areas with high burden and high potential for rapid gains in testing, treatment coverage, and prevention uptake. Overall, the grant is best understood as a targeted boost to an existing CDC/PEPFAR-supported program, intended to help Mozambique move faster toward epidemic control through intensified implementation of proven HIV treatment and prevention interventions in priority districts and provinces.
FAQs: Meeting PEPFAR's accelerated targets for HIV in Mozambique (CDC RFA GH15-1556SUPP16)
What is the title of this grant opportunity?
The opportunity is titled "Meeting PEPFAR's accelerated targets for HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which agency is funding and issuing this opportunity?
It is issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).
What is the Funding Opportunity Number (FOA) for this grant?
The Funding Opportunity Number is CDC RFA GH15-1556SUPP16.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.067.
What type of award mechanism is this?
This is a cooperative agreement.
What does it mean that this award is a cooperative agreement?
A cooperative agreement typically indicates that CDC expects to remain closely involved in program direction, oversight, and technical collaboration, rather than providing funds with minimal involvement.
Is this an open competition for new applicants?
No. Eligibility is restricted to JHPIEGO in Mozambique, so it is not open to new applicants.
Who is eligible to apply?
Only JHPIEGO in Mozambique is eligible, based on the eligibility restriction stated in the opportunity.
Is this a new program or supplemental funding to an existing project?
This is supplemental funding intended to expand or intensify work already being carried out by the existing grantee, rather than launching a new program from scratch.
When was the opportunity posted?
The opportunity was posted on January 8, 2016.
What was the application closing date?
The application closing date was March 8, 2016.
How many awards did CDC anticipate making?
CDC anticipated making one award.
What is the award ceiling for this opportunity?
The published award ceiling is listed as 0.
Why might the award ceiling be listed as 0?
As described in the opportunity summary, a ceiling listed as 0 often indicates that the exact funding level is determined through internal budgeting, provided elsewhere in the announcement package, or negotiated based on the approved supplemental scope rather than set as a firm maximum in the public synopsis.
What is the overall purpose of this supplemental cooperative agreement?
The purpose is to speed up progress toward HIV epidemic control in Mozambique by intensifying implementation of proven HIV treatment and prevention interventions under PEPFAR.
What public health problem is this funding responding to in Mozambique?
The opportunity cites Mozambique's generalized HIV epidemic, with an estimated adult prevalence of about 11.5% among people ages 15 to 49.
What major structural barrier to scaling HIV services is highlighted?
The opportunity highlights a severe health care worker shortage in Mozambique, described as one of the most severe globally, which can limit the pace of expanding HIV services even when commodities and medications are available.
What PEPFAR strategy or plan does this supplemental funding support?
The supplemental award supports PEPFAR's accelerated plan in Mozambique.
How does this work align with the UNAIDS Fast-Track 90-90-90 targets?
The accelerated plan is described as aligning U.S. Government priorities with the UNAIDS Fast-Track 90-90-90 targets: 90% of people living with HIV know their status, 90% of those diagnosed receive sustained antiretroviral therapy, and 90% of those on therapy achieve viral suppression.
What broader PEPFAR policy direction is referenced in the opportunity?
The announcement references broader PEPFAR policy objectives, including the AIDS-Free Generation policy direction, emphasizing rapid scale-up of high-impact interventions to reduce new infections and HIV-related deaths.
What is the key service delivery goal stated for treatment coverage?
The key service delivery goal is to reach 80% coverage for HIV treatment in prioritized districts.
Besides treatment, what core HIV services are included in the accelerated approach?
The opportunity lists accelerated coverage for HIV testing and counseling, prevention of mother-to-child transmission (PMTCT), and voluntary medical male circumcision (VMMC), alongside intensified treatment delivery.
How is HIV testing and counseling positioned within the program?
HIV testing and counseling is described as a core service to identify people living with HIV earlier.
What is the role of PMTCT in the supplemental activities?
PMTCT is included as a core service to reduce infant HIV infections and improve maternal outcomes.
Why is VMMC included in the program description?
VMMC is described as a proven HIV prevention strategy in generalized epidemics.
Does the announcement describe entirely new activities?
No. The announcement indicates the supplemental work is meant to build directly on the existing grantee's platform and ongoing implementation, increasing the speed and intensity of delivery to meet accelerated targets.
Where in Mozambique are the supplemental activities geographically focused?
The activities are focused on priority provinces and urban areas: Zambezia, Sofala, Gaza, Maputo Province, and Maputo City.
Why are efforts concentrated in specific provinces and districts?
The opportunity describes a targeted approach typical of PEPFAR acceleration strategies, directing resources to locations with high burden and strong potential for rapid gains in testing, treatment coverage, and prevention uptake.
What is the grant intended to accomplish overall?
Overall, it is intended as a targeted boost to an existing CDC/PEPFAR-supported program to help Mozambique move faster toward epidemic control through intensified implementation of proven HIV treatment and prevention interventions in priority districts and provinces.
Browse more opportunities from the same category: Health
Next opportunity: Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)
Previous opportunity: Mozambique: Supporting Indigenous Organizations to implement and Expand Comprehensive HIV/AIDS Prevention, Care and Treatment in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1556SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1556SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa under PEPFAR Apply for CDC RFA GH11 1109SUPP16 Funding Number: CDC RFA GH11 1109SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR Apply for CDC RFA GH11 1152SUPP16 Funding Number: CDC RFA GH11 1152SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR Apply for CDC RFA GH11 1154SUPP16 Funding Number: CDC RFA GH11 1154SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The USAID Global Health Development Innovation Accelerator Broad Agency Announcement (BAA) Addendum 03 Apply for BAA GLOBALHEALTH 2016 Funding Number: BAA GLOBALHEALTH 2016 Agency: USAID Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs Apply for RFA PS 14 00403CONT16 Funding Number: RFA PS 14 00403CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Apply for PAR 16 070 Funding Number: PAR 16 070 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Establishment of a Strategic Partnership to Strengthen the South African National AIDS Council (SANAC) under PEPFAR Apply for CDC RFA GH13 1338SUPP16 Funding Number: CDC RFA GH13 1338SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR Apply for CDC RFA GH15 1574SUPP16 Funding Number: CDC RFA GH15 1574SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1584CONT16 Funding Number: CDC RFA GH15 1584CONT16 Agency: HHS-CDC Category: Health Funding Amount: $685,000 |
| Comprehensive Facility-Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under PEPFAR Apply for CDC RFA GH12 1257SUPP16 Funding Number: CDC RFA GH12 1257SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Secretary’s Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 141003CONT16 Funding Number: CDC RFA PS14 141003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP16 1607 Funding Number: CDC RFA DP16 1607 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $500,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130204CONT16 Funding Number: CDC RFA DP13 130204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Ryan White HIV/AIDS Program Recipient Capacity to Engage People Living with HIV in Health Care Access Apply for HRSA 16 081 Funding Number: HRSA 16 081 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Part C Capacity Development Program Apply for HRSA 16 088 Funding Number: HRSA 16 088 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121005CONT16 Funding Number: CDC RFA DP12 121005CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 16 081 Funding Number: PAR 16 081 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment Apply for RFA PS 16 002 Funding Number: RFA PS 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| NIDCD National Human Ear Tissue Laboratory Resource for Hearing and Balance Research (U24) Apply for RFA DC 17 001 Funding Number: RFA DC 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $475,000 |
| 2016 Cooperative Agreements to Benefit Homeless Individuals (Short Title: CABHI) Apply for SM 16 007 Funding Number: SM 16 007 Agency: HHS-SAMHS Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1556SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.